HER2-amplified cervical gastric-type mucinous carcinoma with a primitive enterocyte phenotype.

Szczegóły

Tytuł:: HER2-amplified cervical gastric-type mucinous carcinoma with a primitive enterocyte phenotype.
Autorzy:: Fujimoto M; Department of Diagnostic Pathology, Kyoto University, Kyoto, Japan.
Minamiguchi S; Department of Diagnostic Pathology, Kyoto University, Kyoto, Japan.
Ishida A; Department of Diagnostic Pathology, Kyoto University, Kyoto, Japan.
Sumiyoshi S; Department of Diagnostic Pathology, Kyoto University, Kyoto, Japan.
Horikawa N; Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan.
Chigusa Y; Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan.
Mandai M; Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan.
Haga H; Department of Diagnostic Pathology, Kyoto University, Kyoto, Japan.
Źródło:: Histopathology [Histopathology] 2020 Sep; Vol. 77 (3), pp. 511-513. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji:: Case Reports; Letter
Język:: English
Imprint Name(s):: Original Publication: Oxford, Blackwell Scientific Publications.
MeSH Terms:: Adenocarcinoma, Mucinous*/diagnosis
Adenocarcinoma, Mucinous*/metabolism
Adenocarcinoma, Mucinous*/pathology
Cervix Uteri/*pathology
Receptor, ErbB-2/*metabolism
Adenocarcinoma, Clear Cell/diagnosis ; Adenocarcinoma, Clear Cell/pathology ; Biomarkers, Tumor/metabolism ; Colposcopy ; Diagnosis, Differential ; Endodermal Sinus Tumor/diagnosis ; Endodermal Sinus Tumor/pathology ; Female ; Humans ; Immunohistochemistry ; Middle Aged
References:: Kojima A, Mikami Y, Sudo T et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am. J. Surg. Pathol. 2007; 31; 664-672.
Fujimoto M, Matsuzaki I, Nishino M et al. Her2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types. J. Clin. Pathol. 2018; 71; 600-607.
Cao D, Guo S, Allan RW, Molberg KH, Peng Y. Sall4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am. J. Surg. Pathol. 2009; 33; 894-904.
Tornillo L, Moch H, Diener PA, Lugli A, Singer G. CDX-2 immunostaining in primary and secondary ovarian carcinomas. J. Clin. Pathol. 2004; 57; 641-643.
Nogales FF, Prat J, Schuldt M et al. Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells. Histopathology 2018; 72; 634-647.
Carleton C, Hoang L, Sah S et al. A detailed immunohistochemical analysis of a large series of cervical and vaginal gastric-type adenocarcinomas. Am. J. Surg. Pathol. 2016; 40; 636-644.
Contributed Indexing:: Keywords: HER2; clear cell carcinoma; gastric-type mucinous carcinoma with primitive enterocyte phenotype; retro-differentiation; yolk sac tumor
Substance Nomenclature:: 0 (Biomarkers, Tumor)
EC 2.7.10.1 (ERBB2 protein, human)
EC 2.7.10.1 (Receptor, ErbB-2)
Entry Date(s):: Date Created: 20200419 Date Completed: 20210621 Latest Revision: 20210621
Update Code:: 20240104
DOI:: 10.1111/his.14119
PMID:: 32304250
: Raport

Pełny tekst

Informacja